Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Hormone Therapy After Menopause and Artery Wall Composition
2007-005109-23Phase 3Terminated
- Sponsor
- Akademiska sjukhuset
- Start
- Jun 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in atherosclerosis and vascular ageing (VA) comparing Low-dose hormone replacement therapy with Placebo (2 arms). Primary endpoints: Change in carotid artery intima thickness, Change in carotid artery media thickness and 1 more. Started Jun 2009; status: terminated.
02
Drugs
estradiol valerate + dydrogesterone
03
Conditions
atherosclerosisvascular ageing (VA)
Beyond the preview
Go deeper on 2007-005109-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005109-23.